186 related articles for article (PubMed ID: 30617142)
1. Long-term Absolute Risk for Cardiovascular Disease Stratified by Fasting Glucose Level.
Bancks MP; Ning H; Allen NB; Bertoni AG; Carnethon MR; Correa A; Echouffo-Tcheugui JB; Lange LA; Lloyd-Jones DM; Wilkins JT
Diabetes Care; 2019 Mar; 42(3):457-465. PubMed ID: 30617142
[TBL] [Abstract][Full Text] [Related]
2. Fasting glucose variability in young adulthood and incident diabetes, cardiovascular disease and all-cause mortality.
Bancks MP; Carson AP; Lewis CE; Gunderson EP; Reis JP; Schreiner PJ; Yano Y; Carnethon MR
Diabetologia; 2019 Aug; 62(8):1366-1374. PubMed ID: 31115643
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes. The Atherosclerosis Risk in Communities (ARIC) Study.
Folsom AR; Szklo M; Stevens J; Liao F; Smith R; Eckfeldt JH
Diabetes Care; 1997 Jun; 20(6):935-42. PubMed ID: 9167103
[TBL] [Abstract][Full Text] [Related]
4. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
[TBL] [Abstract][Full Text] [Related]
5. Fasting glucose levels within the high normal range predict cardiovascular outcome.
Shaye K; Amir T; Shlomo S; Yechezkel S
Am Heart J; 2012 Jul; 164(1):111-6. PubMed ID: 22795290
[TBL] [Abstract][Full Text] [Related]
6. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study.
Meigs JB; Nathan DM; D'Agostino RB; Wilson PW;
Diabetes Care; 2002 Oct; 25(10):1845-50. PubMed ID: 12351489
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study.
McNeill AM; Katz R; Girman CJ; Rosamond WD; Wagenknecht LE; Barzilay JI; Tracy RP; Savage PJ; Jackson SA
J Am Geriatr Soc; 2006 Sep; 54(9):1317-24. PubMed ID: 16970637
[TBL] [Abstract][Full Text] [Related]
8. Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study.
Wannamethee SG; Welsh P; Lennon L; Papacosta O; Whincup PH; Sattar N
Diabetologia; 2016 Sep; 59(9):1904-12. PubMed ID: 27312697
[TBL] [Abstract][Full Text] [Related]
9. Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up.
Preiss D; Welsh P; Murray HM; Shepherd J; Packard C; Macfarlane P; Cobbe S; Ford I; Sattar N
Eur Heart J; 2010 May; 31(10):1230-6. PubMed ID: 20395260
[TBL] [Abstract][Full Text] [Related]
10. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.
; Sarwar N; Gao P; Seshasai SR; Gobin R; Kaptoge S; Di Angelantonio E; Ingelsson E; Lawlor DA; Selvin E; Stampfer M; Stehouwer CD; Lewington S; Pennells L; Thompson A; Sattar N; White IR; Ray KK; Danesh J
Lancet; 2010 Jun; 375(9733):2215-22. PubMed ID: 20609967
[TBL] [Abstract][Full Text] [Related]
11. Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease.
Kanaya AM; Herrington D; Vittinghoff E; Lin F; Bittner V; Cauley JA; Hulley S; Barrett-Connor E
Ann Intern Med; 2005 May; 142(10):813-20. PubMed ID: 15897531
[TBL] [Abstract][Full Text] [Related]
12. Postchallenge hyperglycemia and mortality in a national sample of U.S. adults.
Saydah SH; Miret M; Sung J; Varas C; Gause D; Brancati FL
Diabetes Care; 2001 Aug; 24(8):1397-402. PubMed ID: 11473076
[TBL] [Abstract][Full Text] [Related]
13. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?
DECODE Study Group, European Diabetes Epidemiology Group
Diabetes Care; 2003 Mar; 26(3):688-96. PubMed ID: 12610023
[TBL] [Abstract][Full Text] [Related]
14. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.
Unwin N; Shaw J; Zimmet P; Alberti KG
Diabet Med; 2002 Sep; 19(9):708-23. PubMed ID: 12207806
[TBL] [Abstract][Full Text] [Related]
15. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults.
Onat A; Can G; Çiçek G; Ayhan E; Doğan Y; Kaya H
Acta Diabetol; 2013 Aug; 50(4):519-28. PubMed ID: 21769500
[TBL] [Abstract][Full Text] [Related]
16. Effects of glycaemic control on cardiovascular disease in diabetic American Indians: the Strong Heart Study.
Lu WQ; Resnick HE; Jablonski KA; Jain AK; Jones KL; Robbins DC; Howard BV
Diabet Med; 2004 Apr; 21(4):311-7. PubMed ID: 15049931
[TBL] [Abstract][Full Text] [Related]
17. Fasting glucose level and the risk of incident atherosclerotic cardiovascular diseases.
Park C; Guallar E; Linton JA; Lee DC; Jang Y; Son DK; Han EJ; Baek SJ; Yun YD; Jee SH; Samet JM
Diabetes Care; 2013 Jul; 36(7):1988-93. PubMed ID: 23404299
[TBL] [Abstract][Full Text] [Related]
18. Sex Differences in Coronary Artery Calcium and Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in Adults With Diabetes: The Coronary Calcium Consortium.
Wong ND; Cordola Hsu AR; Rozanski A; Shaw LJ; Whelton SP; Budoff MJ; Nasir K; Miedema MD; Rumberger J; Blaha MJ; Berman DS
Diabetes Care; 2020 Oct; 43(10):2597-2606. PubMed ID: 32816996
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein.
Malik S; Wong ND; Franklin S; Pio J; Fairchild C; Chen R
Diabetes Care; 2005 Mar; 28(3):690-3. PubMed ID: 15735209
[TBL] [Abstract][Full Text] [Related]
20. Optimal fasting glucose levels with regard to cardiovascular and mortality outcomes in people treated with or without antidiabetic medication.
Jung HH; Lee S
Diabetes Obes Metab; 2020 Feb; 22(2):243-253. PubMed ID: 31602755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
